Literature DB >> 94098

Longitudinal studies of lymphocyte response to Toxoplasma antigen in humans infected with T. gondii.

S E Anderson, J L Krahenbuhl, J S Remington.   

Abstract

Toxoplasma antigen-specific lymphocyte transformation was measured in subjects in whom the diagnosis of acute acquired Toxoplasma infection was documented and in whom the time of onset of clinical illness was carefully determined. Neither false positive nor false negative reactions to Toxoplasma antigen were seen in lymphocytes from uninfected subjects or subjects with chronic Toxoplasma infection. Lymphocytes from subjects in both of these control groups responded equally to a different antigen, streptokinase-streptodornase (SK/SD). On the initial determination, the lymphocytes of 7 of 24 subjects with acute Toxoplasma infection of less than 12 months' duration failed to transform to Toxoplasma antigen. Five of these 7 subjects were among a group of 14 who had developed clinical illness less than 3 months previously. To determine when lymphocyte transformation to Toxoplasma antigen developed, longitudinal studies were carried out in subjects with acute Toxoplasma infection whose lumphocytes failed to transform initially to Toxoplasma antigen. It was found that in all patients, lymphocytes transformed with Toxoplasma antigen eventually, though in two patients this occurred between 9 and 12 months after the initial infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 94098

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  12 in total

1.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Antigen specific lymphocyte transformation induced by secreted antigens from Toxoplasma gondii.

Authors:  H P Hughes; C A Connelly; J E Strangeways; L Hudson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

3.  Chronological development of cellular immunity in human toxoplasmosis.

Authors:  W D Johnson
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

4.  Immunological response in experimentally reactivated toxoplasmosis in mice.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

5.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

6.  Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii.

Authors:  T Hara; S Ohashi; Y Yamashita; T Abe; H Hisaeda; K Himeno; R A Good; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Authors:  S Kahi; G J Cozon; T Greenland; M Wallon; F Gay-Andrieu; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Authors:  T Chardès; F Velge-Roussel; P Mevelec; M N Mevelec; D Buzoni-Gatel; D Bout
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

9.  Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon.

Authors:  J Y Channon; L H Kasper
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Delayed hypersensitivity to Toxoplasma and unrelated antigens in Toxoplasma-infected mice: induction and elicitation of delayed-type hypersensitivity by antigen-pulsed macrophages.

Authors:  E Handman; P M Chester; J S Remington
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.